Back to top
more

Cardinal Health (CAH)

(Delayed Data from NYSE)

$113.28 USD

113.28
1,294,834

+0.11 (0.10%)

Updated Sep 16, 2024 04:00 PM ET

After-Market: $113.27 -0.01 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (160 out of 251)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Here's Why You Should Retain Cardinal Health (CAH) Stock Now

by Zacks Equity Research

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and a diversified product portfolio. However, contraction in gross margin is a woe.

Should Value Investors Pick Cardinal Health (CAH) Stock Now?

by Zacks Equity Research

Let's see if Cardinal Health (CAH) stock is a good choice for value-oriented investors right now from multiple angles.

Cardinal Health (CAH) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Cardinal Health (CAH) closed at $52.61 in the latest trading session, marking a +0.08% move from the prior day.

Cardinal Health (CAH) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

Cardinal Health's (CAH) fiscal second-quarter results benefit from a solid performance in the Pharmaceutical segment.

Cardinal Health (CAH) Beats Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Cardinal (CAH) delivered earnings and revenue surprises of 3.25% and 1.02%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Cardinal Health (CAH) to Post Q2 Earnings: What's in Store?

by Zacks Equity Research

Cardinal Health's (CAH) fiscal second-quarter results are likely to reflect solid performance in the Pharmaceutical segment.

Cardinal Health (CAH) Gains But Lags Market: What You Should Know

by Zacks Equity Research

Cardinal Health (CAH) closed at $52.63 in the latest trading session, marking a +0.61% move from the prior day.

Analysts Estimate Cardinal Health (CAH) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Cardinal (CAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Broadcom and Cardinal Health have been highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Broadcom and Cardinal Health have been highlighted as Zacks Bull and Bear of the Day.

David Bartosiak headshot

Bear of the Day: Cardinal Health (CAH)

by David Bartosiak

Earnings are not as healthy as they could be.

    New Strong Sell Stocks for January 12th

    by Zacks Equity Research

    ASH, CAH, and ESTA have been added to the Zacks Rank #5 (Strong Sell) List on January 12, 2022

    Here's Why You Should Retain Cardinal Health (CAH) Stock Now

    by Zacks Equity Research

    Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and diversified product portfolio. However, contraction in gross margin is a woe.

    Here's Why You Should Retain Cardinal Health (CAH) Stock Now

    by Zacks Equity Research

    Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and diversified product portfolio. However, contraction in gross margin is a woe.

    Zacks Industry Outlook Highlights: McKesson Corp, West Pharmaceutical and Cardinal Health

    by Zacks Equity Research

    Zacks Industry Outlook Highlights: McKesson Corp, West Pharmaceutical and Cardinal Health

    Trina Mukherjee headshot

    3 Promising Stocks From the Buoyant Dental Supplies Industry

    by Trina Mukherjee

    Despite the COVID-19 pandemic induced challenges, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.

    Cardinal Health's (CAH) Arm Unveils Supply Automation Solution

    by Zacks Equity Research

    Cardinal Health's (CAH) business introduces new offering for clinical labs that can enable them to focus on patient care.

    Cardinal Health (CAH) Q1 Earnings Lag, Revenues Top Estimates

    by Zacks Equity Research

    Although Cardinal Health (CAH) witnessed gross margin contraction in its fiscal first-quarter results, rise in revenues in both its segments is encouraging.

    Cardinal Health (CAH) Misses Q1 Earnings Estimates

    by Zacks Equity Research

    Cardinal (CAH) delivered earnings and revenue surprises of -2.27% and 5.29%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

    Cardinal Health (CAH) to Post Q1 Earnings: What's in Store?

    by Zacks Equity Research

    Cardinal Health's (CAH) fiscal first-quarter results are likely to reflect solid performance in the Pharmaceutical segment.

    Analysts Estimate Cardinal Health (CAH) to Report a Decline in Earnings: What to Look Out for

    by Zacks Equity Research

    Cardinal (CAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Cardinal Health's (CAH) Unit Ties Up to Boost Diabetes Care

    by Zacks Equity Research

    Cardinal Health's (CAH) company, OptiFreight Logistics', recent collaboration with Journey Biosciences to help patients with respect to long-term diabetes care.

    Cardinal Health's (CAH) Unit to Aid Canadian Healthcare System

    by Zacks Equity Research

    Cardinal Health's (CAH) subsidiary to support the Canadian Healthcare system against COVID-19 with vaccination policy.

    Here's Why You Should Retain AmerisourceBergen (ABC) Stock Now

    by Zacks Equity Research

    AmerisourceBergen (ABC) continues to gain traction from the robust pharmaceutical segment.

    Cardinal Health (CAH) Q4 Earnings Lag, Revenues Top Estimates

    by Zacks Equity Research

    Although Cardinal Health (CAH) witnessed margin contraction in its fiscal fourth-quarter results, rise in revenues in both its segments is encouraging.

    Cardinal Health (CAH) Lags Q4 Earnings Estimates

    by Zacks Equity Research

    Cardinal (CAH) delivered earnings and revenue surprises of -34.75% and 6.63%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?